This scientific session highlights the clinical importance of CKM-related comorbidities in diabetes, including hypertension, obesity, and drug-induced hyperkalemia. In this session, experts will discuss their prevalence, clinical burden, and practical management strategies across the various comorbidities, while exploring emerging treatment paradigms that may contribute to CKM-based care and support improved long-term outcomes for people with diabetes.